Sandoz Group AG (Sandoz Group AG) Other Long-Term Liabilities : $588 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG Other Long-Term Liabilities?

Sandoz Group AG's other long-term liabilities for the quarter that ended in Dec. 2023 was $588 Mil.

Sandoz Group AG's quarterly other long-term liabilities increased from . 20 ($0 Mil) to Dec. 2022 ($528 Mil) and increased from Dec. 2022 ($528 Mil) to Dec. 2023 ($588 Mil).

Sandoz Group AG's annual other long-term liabilities increased from . 20 ($0 Mil) to Dec. 2022 ($528 Mil) and increased from Dec. 2022 ($528 Mil) to Dec. 2023 ($588 Mil).

Sandoz Group AG Other Long-Term Liabilities Historical Data

The historical data trend for Sandoz Group AG's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG Other Long-Term Liabilities Chart

Sandoz Group AG Annual Data

Trend

Dec22

Dec23

Other Long-Term Liabilities

Sandoz Group AG Quarterly Data
	Dec22	Dec23
Other Long-Term Liabilities	-	-

Sandoz Group AG Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Sandoz Group AG Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sandoz Group AG (Sandoz Group AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZNY) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

SDZXF:USA SDZz:UK D8Y0:Germany SDZ:Switzerland

Address

Forum 1, Novartis Campus, Basel, CHE, CH-4056

Website

https://www.sandoz.com

Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as U.S.'s first biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in pipeline.

Sandoz Group AG (Sandoz Group AG) Headlines

From GuruFocus

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024